<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.11.81 (http://www.squarespace.com/) on Thu, 23 Feb 2012 22:26:07 GMT--><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"><channel><title>COS 2011</title><link>http://www.wholelottarob.com/cos-2011/</link><description>My editorialized view of glaucoma related talks presented at the Canadian Ophthalmological Society annual meeting June 2011 in Vancouver, BC</description><lastBuildDate>Wed, 04 Jan 2012 06:07:38 +0000</lastBuildDate><copyright></copyright><language>en-US</language><generator>Squarespace Site Server v5.11.81 (http://www.squarespace.com/)</generator><item><title>Insights on glaucoma surgery and far beyond (Dr Eytan Blumenthal)</title><category>Glaucoma</category><category>surgery</category><dc:creator>Robert M Schertzer, MD, MEd, FRCSC</dc:creator><pubDate>Wed, 04 Jan 2012 06:07:26 +0000</pubDate><link>http://www.wholelottarob.com/cos-2011/2012/1/3/insights-on-glaucoma-surgery-and-far-beyond-dr-eytan-blument.html</link><guid isPermaLink="false">352979:10756246:11792934</guid><description><![CDATA[Dr Eytan Blumenthal, one of our invited speakers, prepared an entertaining and thought provoking talk about glaucoma surgery and the cocept of feedback loops. Writing an article about his talk is akin to dancing about architecture. Nonetheless, here are my notes and thoughts about his lecture.
]]></description><wfw:commentRss>http://www.wholelottarob.com/cos-2011/rss-comments-entry-11792934.xml</wfw:commentRss></item><item><title>Mechanisms of BAK toxicity in a human trabecular meshwork cell line (Drs Cindy Hutnik, Angela Q. Zhang, Christopher Byrne, Grayson A. Roumeliotis, Cindy Shao, Hong Liu)</title><category>BAK</category><category>Glaucoma</category><category>HTM</category><category>Trabecular Meshwork</category><category>preservatives</category><category>toxicity</category><dc:creator>Robert M Schertzer, MD, MEd, FRCSC</dc:creator><pubDate>Mon, 05 Dec 2011 12:00:57 +0000</pubDate><link>http://www.wholelottarob.com/cos-2011/2011/12/5/mechanisms-of-bak-toxicity-in-a-human-trabecular-meshwork-ce.html</link><guid isPermaLink="false">352979:10756246:11792937</guid><description><![CDATA[With no new classes of glaucoma medications since 1996, there is increased focus on preservatives and whether they are toxic. Is this as bad as the buzz on the street?
]]></description><wfw:commentRss>http://www.wholelottarob.com/cos-2011/rss-comments-entry-11792937.xml</wfw:commentRss></item><item><title>Preservative exposure and surgical outcomes in glaucoma patients: The PESO study (Drs Corey Boimer &amp; Catherine Birt)</title><category>BAK</category><category>Glaucoma</category><category>preservatives</category><category>surgery</category><category>toxicity</category><dc:creator>Robert M Schertzer, MD, MEd, FRCSC</dc:creator><pubDate>Fri, 02 Dec 2011 20:24:35 +0000</pubDate><link>http://www.wholelottarob.com/cos-2011/2011/12/2/preservative-exposure-and-surgical-outcomes-in-glaucoma-pati.html</link><guid isPermaLink="false">352979:10756246:11792938</guid><description><![CDATA[Generally medical first line therapy but risk early failure from med Tx. Is it the med or preservative that is the culprit? Benzalkonium Chloride (BAK) is a detergent that does cause conjunctival metaplasia. The purpose of this study was to identify if BAK causes poorer glaucoma surgical outcomes based on a retrospective review.
]]></description><wfw:commentRss>http://www.wholelottarob.com/cos-2011/rss-comments-entry-11792938.xml</wfw:commentRss></item><item><title>CJO Lecture: Epidemiology of glaucoma – What's new? (Dr Colin Cook)</title><category>Epidemiology</category><category>Glaucoma</category><category>angle closure glaucoma</category><category>screening</category><dc:creator>Robert M Schertzer, MD, MEd, FRCSC</dc:creator><pubDate>Thu, 06 Oct 2011 22:10:55 +0000</pubDate><link>http://www.wholelottarob.com/cos-2011/2011/10/6/cjo-lecture-epidemiology-of-glaucoma-whats-new-dr-colin-cook.html</link><guid isPermaLink="false">352979:10756246:11792939</guid><description><![CDATA[Prevalence of glaucoma increasing due to aging of the population. Angle closure more likely to lead to blindness. ACG more common in Asia and in the Inuit population. As for INCIDENCE data, which is needed to plan for our care needs, but much harder to do.
]]></description><wfw:commentRss>http://www.wholelottarob.com/cos-2011/rss-comments-entry-11792939.xml</wfw:commentRss></item><item><title>My patient has an optic disc hemorrhage (ODH): What does it mean? What do I do now? (Dr Dale Heuer)</title><category>Glaucoma</category><category>ODH</category><category>Optic Disc Haemmorhage</category><category>Optic Disc Hemmorhage</category><dc:creator>Robert M Schertzer, MD, MEd, FRCSC</dc:creator><pubDate>Tue, 26 Jul 2011 20:44:26 +0000</pubDate><link>http://www.wholelottarob.com/cos-2011/2011/7/26/my-patient-has-an-optic-disc-hemorrhage-odh-what-does-it-mea.html</link><guid isPermaLink="false">352979:10756246:11757719</guid><description><![CDATA[Are disc heme&#8217;s glaucoma&#8217;s HgB A1C? You are only checking your patient&#8217;s 1/10,000 of the time even if you see your patient every 3 months. So only a fraction of their time. Does ODH predict damage in the future?
]]></description><wfw:commentRss>http://www.wholelottarob.com/cos-2011/rss-comments-entry-11757719.xml</wfw:commentRss></item></channel></rss>
